The blood filtration and purification market size has grown rapidly in recent years. It will grow from $4.38 billion in 2025 to $4.83 billion in 2026 at a compound annual growth rate (CAGR) of 10.3%. The growth in the historic period can be attributed to reliance on manual blood purification methods, limited availability of advanced filtration membranes, growing prevalence of infectious and chronic diseases, increasing hospital and clinical lab setups, adoption of conventional sample preparation techniques.
The blood filtration and purification market size is expected to see rapid growth in the next few years. It will grow to $7.12 billion in 2030 at a compound annual growth rate (CAGR) of 10.2%. The growth in the forecast period can be attributed to development of automated and high-throughput filtration systems, rising research in genetic and molecular diagnostics, growing investment in clinical diagnostic labs, increasing demand for disposable and specialized kits, technological advancements in membrane and assay design. Major trends in the forecast period include growing adoption of automated blood filtration systems, increasing demand for disposable filtration kits and reagents, rising use of specialty assays and columns in diagnostics, expansion of membranes, filters, and consumables segment, enhanced focus on sample preparation and blood purification efficiency.
The increasing prevalence of blood-related disorders is expected to drive the growth of the blood filtration and purification market in the coming years. Blood-related disorders are medical conditions that affect the cells, components, or functions of blood. The rise in these disorders is largely attributed to the aging global population, as older individuals are more susceptible to conditions that impact blood health, leading to higher incidence rates and increased demand for diagnosis and treatment. Blood filtration and purification systems support the management of blood-related disorders by effectively removing toxins and harmful substances from the bloodstream, helping to restore normal blood function and reduce disease symptoms. For instance, in November 2024, the American Society of Hematology, a US-based non-profit organization, projected that new leukemia cases in the United States will rise to 519,540 by 2050. As a result, the growing prevalence of blood-related disorders is contributing to the expansion of the blood filtration and purification market.
Leading companies in the blood filtration and purification market are focusing on developing advanced solutions, such as improved touchscreen interfaces, to provide user-friendly systems that simplify dialysis procedures and enhance the patient experience in home-based therapies. The enhanced touchscreen interface offers an upgraded, intuitive display with improved graphics and navigation, making it easier to operate home hemodialysis systems. For instance, in August 2023, Fresenius Medical Care, a Germany-based healthcare company, received FDA clearance for VersiHD with GuideMe Software. This state-of-the-art home hemodialysis system combines a reliable dialysis machine with a self-guided, intuitive interface designed to make treatment more accessible for patients and caregivers. It provides clear, step-by-step visual instructions to enhance usability, boost patient confidence, and reduce training time, enabling more individuals to manage dialysis at home. Leveraging NxStage’s extensive experience in home hemodialysis, this system delivers effective blood filtration and purification for patients with chronic kidney disease, allowing them to safely and comfortably perform dialysis independently.
In December 2024, GVS S.p.A., an Italy-based filtration solutions company, acquired the whole blood business of Haemonetics Corporation for an undisclosed sum. Through this acquisition, GVS S.p.A. seeks to expand its product portfolio by incorporating Haemonetics’ specialized blood collection, processing, filtration, and transfusion technologies. Haemonetics Corporation, a US-based company, offers a range of blood management solutions, including blood filtration and purification.
Major companies operating in the blood filtration and purification market are Thermo Fisher Scientific Inc., Asahi Kasei Corporation, Fresenius SE & Co. KGaA, Toray Industries Inc., Baxter International Inc., DaVita Inc., Kaneka Corporation, Nipro Corporation, Nikkiso Co. Ltd., Jafron Biomedical Co. Ltd., Satellite Healthcare Inc., B. Braun Melsungen AG, Biotage AB, CytoSorbents Europe GmbH, Medica S.p.A., SWS Medical Group, Spectral Medical Inc., ExThera Medical Corporation, Infomed SA, Baihe Medical Co. Ltd., Guangdong Biolight Meditech Co. Ltd.
North America was the largest region in the blood filtration and purification market in 2025. Asia Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the blood filtration and purification market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the blood filtration and purification market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are impacting the blood filtration and purification market by increasing the cost of imported membranes, reagents, and automated sample preparation systems. Segments such as hollow fiber membranes, specialty assay columns, and filtration kits are most affected, with Asia-Pacific regions including China and India experiencing significant import duties. This has resulted in higher production costs and supply chain delays. On the positive side, tariffs encourage local manufacturing, adoption of alternative materials, and greater investment in domestic production capabilities, fostering market resilience.
The blood filtration and purification market research report is one of a series of new reports that provides blood filtration and purification market statistics, including blood filtration and purification industry global market size, regional shares, competitors with a blood filtration and purification market share, detailed blood filtration and purification market segments, market trends and opportunities, and any further data you may need to thrive in the blood filtration and purification industry. This blood filtration and purification market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Blood filtration and purification is a medical procedure designed to remove impurities, toxins, excess fluids, or harmful substances from the blood, helping restore its normal composition and improve patient health. This process employs specialized devices and techniques to clean the blood outside the body before returning it, supporting organ function, controlling infections, and maintaining physiological balance in critically ill patients.
The primary products in blood filtration and purification include filtration kits and reagents, membranes, filters and consumables, sample preparation systems, and specialty assays and columns. Filtration kits and reagents consist of specialized components and chemicals used in medical and laboratory procedures to filter and prepare blood or biological samples. These products are applied in infectious disease diagnostics, toxicology and immunodiagnostics, cancer diagnostics, genetic or molecular diagnostics, and more. Key end users include clinical diagnostic laboratories, hospitals, research and academic institutions, and other healthcare facilities.
The blood filtration and purification market consists of revenues earned by entities by provide services such as therapeutic blood purification procedures, separation services, and support for biopharmaceutical manufacturing. The market value includes the value of related goods sold by the service provider or included within the service offering. The blood filtration and purification market also includes sales of blood filters, diagnostic tools, and replacement therapy accessories. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
The blood filtration and purification market size is expected to see rapid growth in the next few years. It will grow to $7.12 billion in 2030 at a compound annual growth rate (CAGR) of 10.2%. The growth in the forecast period can be attributed to development of automated and high-throughput filtration systems, rising research in genetic and molecular diagnostics, growing investment in clinical diagnostic labs, increasing demand for disposable and specialized kits, technological advancements in membrane and assay design. Major trends in the forecast period include growing adoption of automated blood filtration systems, increasing demand for disposable filtration kits and reagents, rising use of specialty assays and columns in diagnostics, expansion of membranes, filters, and consumables segment, enhanced focus on sample preparation and blood purification efficiency.
The increasing prevalence of blood-related disorders is expected to drive the growth of the blood filtration and purification market in the coming years. Blood-related disorders are medical conditions that affect the cells, components, or functions of blood. The rise in these disorders is largely attributed to the aging global population, as older individuals are more susceptible to conditions that impact blood health, leading to higher incidence rates and increased demand for diagnosis and treatment. Blood filtration and purification systems support the management of blood-related disorders by effectively removing toxins and harmful substances from the bloodstream, helping to restore normal blood function and reduce disease symptoms. For instance, in November 2024, the American Society of Hematology, a US-based non-profit organization, projected that new leukemia cases in the United States will rise to 519,540 by 2050. As a result, the growing prevalence of blood-related disorders is contributing to the expansion of the blood filtration and purification market.
Leading companies in the blood filtration and purification market are focusing on developing advanced solutions, such as improved touchscreen interfaces, to provide user-friendly systems that simplify dialysis procedures and enhance the patient experience in home-based therapies. The enhanced touchscreen interface offers an upgraded, intuitive display with improved graphics and navigation, making it easier to operate home hemodialysis systems. For instance, in August 2023, Fresenius Medical Care, a Germany-based healthcare company, received FDA clearance for VersiHD with GuideMe Software. This state-of-the-art home hemodialysis system combines a reliable dialysis machine with a self-guided, intuitive interface designed to make treatment more accessible for patients and caregivers. It provides clear, step-by-step visual instructions to enhance usability, boost patient confidence, and reduce training time, enabling more individuals to manage dialysis at home. Leveraging NxStage’s extensive experience in home hemodialysis, this system delivers effective blood filtration and purification for patients with chronic kidney disease, allowing them to safely and comfortably perform dialysis independently.
In December 2024, GVS S.p.A., an Italy-based filtration solutions company, acquired the whole blood business of Haemonetics Corporation for an undisclosed sum. Through this acquisition, GVS S.p.A. seeks to expand its product portfolio by incorporating Haemonetics’ specialized blood collection, processing, filtration, and transfusion technologies. Haemonetics Corporation, a US-based company, offers a range of blood management solutions, including blood filtration and purification.
Major companies operating in the blood filtration and purification market are Thermo Fisher Scientific Inc., Asahi Kasei Corporation, Fresenius SE & Co. KGaA, Toray Industries Inc., Baxter International Inc., DaVita Inc., Kaneka Corporation, Nipro Corporation, Nikkiso Co. Ltd., Jafron Biomedical Co. Ltd., Satellite Healthcare Inc., B. Braun Melsungen AG, Biotage AB, CytoSorbents Europe GmbH, Medica S.p.A., SWS Medical Group, Spectral Medical Inc., ExThera Medical Corporation, Infomed SA, Baihe Medical Co. Ltd., Guangdong Biolight Meditech Co. Ltd.
North America was the largest region in the blood filtration and purification market in 2025. Asia Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the blood filtration and purification market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the blood filtration and purification market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are impacting the blood filtration and purification market by increasing the cost of imported membranes, reagents, and automated sample preparation systems. Segments such as hollow fiber membranes, specialty assay columns, and filtration kits are most affected, with Asia-Pacific regions including China and India experiencing significant import duties. This has resulted in higher production costs and supply chain delays. On the positive side, tariffs encourage local manufacturing, adoption of alternative materials, and greater investment in domestic production capabilities, fostering market resilience.
The blood filtration and purification market research report is one of a series of new reports that provides blood filtration and purification market statistics, including blood filtration and purification industry global market size, regional shares, competitors with a blood filtration and purification market share, detailed blood filtration and purification market segments, market trends and opportunities, and any further data you may need to thrive in the blood filtration and purification industry. This blood filtration and purification market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Blood filtration and purification is a medical procedure designed to remove impurities, toxins, excess fluids, or harmful substances from the blood, helping restore its normal composition and improve patient health. This process employs specialized devices and techniques to clean the blood outside the body before returning it, supporting organ function, controlling infections, and maintaining physiological balance in critically ill patients.
The primary products in blood filtration and purification include filtration kits and reagents, membranes, filters and consumables, sample preparation systems, and specialty assays and columns. Filtration kits and reagents consist of specialized components and chemicals used in medical and laboratory procedures to filter and prepare blood or biological samples. These products are applied in infectious disease diagnostics, toxicology and immunodiagnostics, cancer diagnostics, genetic or molecular diagnostics, and more. Key end users include clinical diagnostic laboratories, hospitals, research and academic institutions, and other healthcare facilities.
The blood filtration and purification market consists of revenues earned by entities by provide services such as therapeutic blood purification procedures, separation services, and support for biopharmaceutical manufacturing. The market value includes the value of related goods sold by the service provider or included within the service offering. The blood filtration and purification market also includes sales of blood filters, diagnostic tools, and replacement therapy accessories. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Blood Filtration and Purification Market Characteristics
3. Blood Filtration and Purification Market Supply Chain Analysis
4. Global Blood Filtration and Purification Market Trends and Strategies
5. Blood Filtration and Purification Market Analysis of End Use Industries
7. Global Blood Filtration and Purification Strategic Analysis Framework, Current Market Size, Market Comparisons and Growth Rate Analysis
8. Global Blood Filtration and Purification Total Addressable Market (TAM) Analysis for the Market
9. Blood Filtration and Purification Market Segmentation
10. Blood Filtration and Purification Market Regional and Country Analysis
11. Asia-Pacific Blood Filtration and Purification Market
12. China Blood Filtration and Purification Market
13. India Blood Filtration and Purification Market
14. Japan Blood Filtration and Purification Market
15. Australia Blood Filtration and Purification Market
16. Indonesia Blood Filtration and Purification Market
17. South Korea Blood Filtration and Purification Market
18. Taiwan Blood Filtration and Purification Market
19. South East Asia Blood Filtration and Purification Market
20. Western Europe Blood Filtration and Purification Market
21. UK Blood Filtration and Purification Market
22. Germany Blood Filtration and Purification Market
23. France Blood Filtration and Purification Market
24. Italy Blood Filtration and Purification Market
25. Spain Blood Filtration and Purification Market
26. Eastern Europe Blood Filtration and Purification Market
27. Russia Blood Filtration and Purification Market
28. North America Blood Filtration and Purification Market
29. USA Blood Filtration and Purification Market
30. Canada Blood Filtration and Purification Market
31. South America Blood Filtration and Purification Market
32. Brazil Blood Filtration and Purification Market
33. Middle East Blood Filtration and Purification Market
34. Africa Blood Filtration and Purification Market
36. Blood Filtration and Purification Market Competitive Landscape and Company Profiles
37. Blood Filtration and Purification Market Other Major and Innovative Companies
40. Blood Filtration and Purification Market High Potential Countries, Segments and Strategies
41. Appendix
List of Tables
Executive Summary
Blood Filtration And Purification Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses blood filtration and purification market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for blood filtration and purification? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The blood filtration and purification market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Product: Filtration Kits And Reagents; Membranes, Filters And Consumables; Sample Preparation Systems; Specialty Assays And Columns2) By Application: Infectious Disease Diagnostics; Toxicology And Immunodiagnostics; Cancer Diagnostics; Genetic Or Molecular Diagnostics; Others Applications
3) By End User: Clinical Diagnostic Labs; Hospitals; Research And Academic Institutes; Other End Users
Subsegments:
1) By Filtration Kits And Reagents: Disposable Filtration Kits; Reagent Kits For Blood Purification; Enzyme-Based Reagents; Chemical Reagents; Buffer Solutions2) By Membranes, Filters And Consumables: Hollow Fiber Membranes; Flat Sheet Membranes; Microfiltration Filters; Ultrafiltration Filters; Nanofiltration Filters; Filter Cartridges; Consumable Accessories
3) By Sample Preparation Systems: Automated Sample Preparation Instruments; Manual Sample Preparation Devices; Centrifugation Systems; Blood Separation Units; Cell Sorting Systems
4) By Specialty Assays And Columns: Affinity Chromatography Columns; Ion Exchange Columns; Size Exclusion Columns; Immunoaffinity Assays; Enzymatic Assays
Companies Mentioned: Thermo Fisher Scientific Inc.; Asahi Kasei Corporation; Fresenius SE & Co. KGaA; Toray Industries Inc.; Baxter International Inc.; DaVita Inc.; Kaneka Corporation; Nipro Corporation; Nikkiso Co. Ltd.; Jafron Biomedical Co. Ltd.; Satellite Healthcare Inc.; B. Braun Melsungen AG; Biotage AB; CytoSorbents Europe GmbH; Medica S.p.A.; SWS Medical Group; Spectral Medical Inc.; ExThera Medical Corporation; Infomed SA; Baihe Medical Co. Ltd.; Guangdong Biolight Meditech Co. Ltd.
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits:
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
The companies featured in this Blood Filtration and Purification market report include:- Thermo Fisher Scientific Inc.
- Asahi Kasei Corporation
- Fresenius SE & Co. KGaA
- Toray Industries Inc.
- Baxter International Inc.
- DaVita Inc.
- Kaneka Corporation
- Nipro Corporation
- Nikkiso Co. Ltd.
- Jafron Biomedical Co. Ltd.
- Satellite Healthcare Inc.
- B. Braun Melsungen AG
- Biotage AB
- CytoSorbents Europe GmbH
- Medica S.p.A.
- SWS Medical Group
- Spectral Medical Inc.
- ExThera Medical Corporation
- Infomed SA
- Baihe Medical Co. Ltd.
- Guangdong Biolight Meditech Co. Ltd.
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | February 2026 |
| Forecast Period | 2026 - 2030 |
| Estimated Market Value ( USD | $ 4.83 Billion |
| Forecasted Market Value ( USD | $ 7.12 Billion |
| Compound Annual Growth Rate | 10.2% |
| Regions Covered | Global |
| No. of Companies Mentioned | 22 |
